Tirzepatide

Tirzepatide is a synthetic 39-amino acid peptide that acts as a dual agonist of GIP and GLP-1 receptors. It enhances insulin secretion, lowers blood sugar, and supports weight loss. Designed with unique modifications for extended stability and efficacy, tirzepatide offers a promising approach for managing type 2 diabetes and obesity.

Being studied for:

Obesity and weight management

Heart failure with preserved ejection fraction (HFpEF)

Non-alcoholic steatohepatitis (NASH)

Chronic kidney disease (CKD)

Obstructive sleep apnea (OSA)

Prediabetes and diabetes prevention

Opioid use disorder (adjunct therapy)